Abstract
Keywords
- Wise J.
European Medicines Agency. Vaxzevria (previously COVID-19 Vaccine AstraZeneca): link between the vaccine and the occurrence of thrombosis in combination with thrombocytopenia. 2021-04-13, https://www.ema.europa.eu/en/medicines/dhpc/vaxzevria-previously-covid-19-vaccine-astrazeneca-link-between-vaccine-occurrence-thrombosis (Accessed 9 May 2021).
- Muir K-L
- Kallam A
- Koepsell SA
- et al.
European Medicines Agency. COVID-19 Vaccine Janssen: link between the vaccine and the occurrence of thrombosis in combination with thrombocytopenia. 2021-04-26, https://www.ema.europa.eu/en/medicines/dhpc/covid-19-vaccine-janssen-link-between-vaccine-occurrence-thrombosis-combination-thrombocytopenia (Accessed 9 May 2021).
- See I
- Su JR
- Lale A
- et al.
Discussion
European Medicines Agency. Vaxzevria (previously COVID-19 Vaccine AstraZeneca): link between the vaccine and the occurrence of thrombosis in combination with thrombocytopenia. 2021-04-13, https://www.ema.europa.eu/en/medicines/dhpc/vaxzevria-previously-covid-19-vaccine-astrazeneca-link-between-vaccine-occurrence-thrombosis (Accessed 9 May 2021).
European Medicines Agency. COVID-19 Vaccine Janssen: link between the vaccine and the occurrence of thrombosis in combination with thrombocytopenia. 2021-04-26, https://www.ema.europa.eu/en/medicines/dhpc/covid-19-vaccine-janssen-link-between-vaccine-occurrence-thrombosis-combination-thrombocytopenia (Accessed 9 May 2021).
European Medicines Agency. EudraVigilance - European database of suspected adverse drug reaction reports, http://www.adrreports.eu / (Accessed 9 May 2021).
Agency EM. AstraZeneca's COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets. European Medicines Agency, https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood (2021, accessed 7 April 2021).
- Scully M
- Singh D
- Lown R
- et al.
Funding
Informed consent
Ethical approval
Guarantor
Contributorship
Declaration of Competing Interest
Acknowledgments
References
- Thromboembolism and the Oxford–AstraZeneca COVID-19 vaccine: side-effect or coincidence?.Lancet. 2021; 397: 1441-1443
- Covid-19: European countries suspend use of Oxford-AstraZeneca vaccine after reports of blood clots.BMJ. 2021; 372 (Epub ahead of print)https://doi.org/10.1136/bmj.n699
European Medicines Agency. Vaxzevria (previously COVID-19 Vaccine AstraZeneca): link between the vaccine and the occurrence of thrombosis in combination with thrombocytopenia. 2021-04-13, https://www.ema.europa.eu/en/medicines/dhpc/vaxzevria-previously-covid-19-vaccine-astrazeneca-link-between-vaccine-occurrence-thrombosis (Accessed 9 May 2021).
- Thrombotic Thrombocytopenia after Ad26.COV2.S vaccination.N Engl J Med. 2021; (Epub ahead of print 14 April)https://doi.org/10.1056/NEJMc2105869
European Medicines Agency. COVID-19 Vaccine Janssen: link between the vaccine and the occurrence of thrombosis in combination with thrombocytopenia. 2021-04-26, https://www.ema.europa.eu/en/medicines/dhpc/covid-19-vaccine-janssen-link-between-vaccine-occurrence-thrombosis-combination-thrombocytopenia (Accessed 9 May 2021).
- US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2021.JAMA. 2021; (Epub ahead of print 30 April)https://doi.org/10.1001/jama.2021.7517
- Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine.N Engl J Med. 2020; 383: 2603-2615
- Do COVID-19 RNA-based vaccines put at risk of immune-mediated diseases? In reply to “potential antigenic cross-reactivity between SARS-CoV-2 and human tissue with a possible link to an increase in autoimmune diseases.Clin Immunol. 2021; 224108665
European Medicines Agency. EudraVigilance - European database of suspected adverse drug reaction reports, http://www.adrreports.eu / (Accessed 9 May 2021).
Agency EM. AstraZeneca's COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets. European Medicines Agency, https://www.ema.europa.eu/en/news/astrazenecas-covid-19-vaccine-ema-finds-possible-link-very-rare-cases-unusual-blood-clots-low-blood (2021, accessed 7 April 2021).
- Pathologic antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 vaccination.N Engl J Med. 2021; (Epub ahead of print 16 April)https://doi.org/10.1056/NEJMoa2105385
Article info
Publication history
Footnotes
This study did not receive grant support.
Identification
DOI: https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.105906